ⓘ Featured image details: CureFit co-founders: Mukesh Bansal (L) and Ankit Nagori (R); Credits: Forbes
Healthcare and wellness startup Curefit today raised INR 832 crore (around $110 million) in its second Series D funding round led by Singapore’s Temasek, with participation from Unilever Venture Holdings and Ascent Capital. The following round came after several quarters of negotiations of CureFit with Softbank Vision Fund which did not go through.
The latest funding deal has valued the company around INR 4,300 crores (around $570 million). CureFit last raised $120 million in June 2019 from a number of investors including Accel, Chiratae, Kalaari, and Oaktree which value the company at INR 3,700 crore.